John W. Brooker & Co., Cp As Moderna, Inc. Transaction History

John W. Brooker & Co., Cp As

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	BUY	$221.9 - $484.47 $22,190 - $48,447	100 Added 200.0%	150 $58,000
Q2 2021 Jul 09, 2021	SELL	$129.91 - $234.98 $9,093 - $16,448	-70 Reduced 58.33%	50 $12,000
Q1 2021 Apr 08, 2021	BUY	$109.18 - $185.98 $7,642 - $13,018	70 Added 140.0%	120 $16,000
Q3 2020 Oct 05, 2020	BUY	$54.34 - $94.85 $2,717 - $4,742	50 New	50 $4,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of John W. Brooker & Co., Cp As, based on Form 13F filings with the SEC.

Stay updated on John W. Brooker & Co., Cp As with notifications on news.